Neus Martinez-Bosch

7PUBLICATIONS
35CO-AUTHORS
Cancer cell biologyPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 08, 2026
PARP2 deficiency impairs pancreatic cancer progression by promoting genomic instability and antitumor immunity.

|Mar 31, 2025
Quantitative characterization of the 3D self-organization of PDAC tumor spheroids reveals cell type and matrix dependence through advanced microscopy analysis.

Soraya Hernández-Hatibi, Carlos Borau, Neus Martínez-Bosch

|Mar 29, 2023
Gal-1 Expression Analysis in the GLIOCAT Multicenter Study: Role as a Prognostic Factor and an Immune-Suppressive Biomarker.

Neus Martínez-Bosch, Noelia Vilariño, Francesc Alameda

|Dec 23, 2022
Sialyltransferase Inhibitor Ac53FaxNeu5Ac Reverts the Malignant Phenotype of Pancreatic Cancer Cells, and Reduces Tumor Volume and Favors T-Cell Infiltrates in Mice.

Laura Miró, Júlia López, Pedro E Guerrero

|Feb 25, 2022
Peptides against Low Density Lipoprotein (LDL) Aggregation Inhibit Intracellular Cholesteryl Ester Loading and Proliferation of Pancreatic Tumor Cells.

Aleyda Benitez-Amaro, Neus Martínez-Bosch, Noemí Manero-Rupérez

|Jul 26, 2020
Impact of Galectins in Resistance to Anticancer Therapies.

Pilar Navarro, Neus Martínez-Bosch, Ada G Blidner

Pageof 2

Frequent Collaborators

6 joint publications

Pilar Navarro

1 joint publications

Judith Vinaixa

1 joint publications

Ada G Blidner

1 joint publications

Aleyda Benitez-Amaro